CPGEA

Introduction

Chinese Prostate Cancer Genome and Epigenome Atlas (CPGEA) is the largest and most comprehensive cancer genomics study conducted in China. Our genome and epigenome roadmap of prostate cancer for Chinese men is consisted of over 1200 genomic datasets from more than 200 pairs of matched normal and primary prostate cancers, providing an invaluable resources and opportunity to complement and compare to previous cancer genomics studies represented by TCGA.

Summary

Alalysis Workflow	Sequencing Info	Somatic Alterations	Validation
DNA-seq	WGS	Somatic coding mutations (MAF File) Somatic CNV (Control-Freec、Gistic) Somatic SV (Meerkat Result)	FOXA1 Mutation Validation SV Validation
RNA-seq	Lnc-RNA Samll RNA	Fusion (SOAPfuse Result、General Result)	Fusion Validation
DNA-methylation	WGBS	DMR (DMR Result)	-

Public Data

Study	Mutations	Fusions	CNAs
cpcg_2017	+
su2c_2015	+	+	+
mskcc_2017	+	+	+
wcm_2016	+		+
broad_2013	+	+	+
broad_2012	+		+
eururol_2017	+	+	+
fhcrc_nm_2016	+		+
mskcc_2010	+		+
mskcc_dfci_ng_2018	+	+	+
tcga_pub	+	+	+
mskcc_2014			+
mskcc_cheny_2014	+
mich_2012	+	+	+